NGM Biopharmaceuticals In... (NGM)
NASDAQ: NGM
· Real-Time Price · USD
1.54
-0.02 (-1.28%)
At close: Apr 03, 2024, 3:59 PM
NGM Biopharmaceuticals Revenue
NGM Biopharmaceuticals reported an annual revenue of $4.42M, reflecting a -92.02% growth. For the quarter ending December 31, 2023, NGM Biopharmaceuticals generated $165K in revenue.
Revenue (ttm)
4.42M
Revenue Growth
-92.02%
Price / Sales Ratio
16.04
Revenue / Employee
32.01K
Employees
138
Market Cap
128.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 4.42M | -92.02% |
| Dec 31, 2022 | 55.33M | -28.95% |
| Dec 31, 2021 | 77.88M | -10.86% |
| Dec 31, 2020 | 87.37M | -15.62% |
| Dec 31, 2019 | 103.54M | -4.71% |
| Dec 31, 2018 | 108.67M | +40.87% |
| Dec 31, 2017 | 77.14M | -9.87% |
| Dec 31, 2016 | 85.59M | n/a |